SYRE: SEC Form 10-Q filed by Spyre Therapeutics Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for SYRE
Across the 27 sessions after earlier SYRE headlines, the stock closed higher 20 times and lower 7 times, with a median move of 2.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | SYRE | SPY |
|---|---|---|---|
| Jul 28, 2026 | Spyre Therapeutics downgraded by Wolfe Research | -0.1% | +0.2% |
| Jul 6, 2026 | Spyre Therapeutics Announces Grants of Inducement Awards | +2.4% | +0.9% |
| Jun 15, 2026 | Spyre Announces Potential Best-in-Class SPY002 (anti-TL1A) Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients | +3.5% | +1.8% |
| Jun 8, 2026 | Spyre Therapeutics Announces Grants of Inducement Awards | -2.2% | +0.2% |
| Jun 3, 2026 | Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA | +6.3% | -0.7% |
| May 27, 2026 | Spyre Therapeutics to Participate in Upcoming June Investor Conferences | -1.5% | -0.0% |
Keep researching SYRE
- SYRE financial statementsRevenue, profit, cash flow and balance sheet from Spyre Therapeutics Inc.'s SEC filings.
- What is Form 10-Q?The quarterly report US public companies file with the SEC for each of the first three fiscal quarters, with unaudited financial statements and MD&A.
- Form 10-K vs 10-QThe difference between a 10-K and a 10-Q: what each report contains, filing deadlines by company size, audited vs reviewed financials, and which sections to read first.
- SYRE insider tradesEvery buy and sale reported by Spyre Therapeutics Inc. officers, directors and large holders.
- SYRE earnings historyPast Spyre Therapeutics Inc. earnings releases, newest first.
Quantisnow market dataNASDAQ
SYRE
Spyre Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2016
Get push alerts for SYRE
Full SYRE profile on Quantisnow Follow SYRE and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time